Analysis of Biomarkers for Acute Graft-versus-Host Disease (GVHD)

Mayo Clinic

Status: Withdrawn

Conditions: Blood Stem Cell Transplant Failure

Study type: Observational

Funder types: Other

Identifiers

NCT01569373

12-001493

Details and patient eligibility

About

Samples of blood and urine will be analyzed for biomarkers to check their predictivity of Graft-versus-Host Disease (GVHD) outcomes.

Full description

To determine if serum biomarkers of inflammation correlate with onset and severity of acute GVHD, particularly GVHD of the gut.

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• 18 years old or older patients
• Undergoing allogeneic stem cell transplant

Exclusion criteria

None

Trial design

0 participants in 1 patient group

Post allogeneic SCT patients

Description:

Patients who have undergone an allogeneic stem cell transplant.